• AI Grand Rounds
  • Posts
  • Neurology's Next Frontier: The Rise of Wearable Tech meaning!!!

Neurology's Next Frontier: The Rise of Wearable Tech meaning!!!

S.M. Benish, D. Friedman, S. Merchant, M.T. Minen, E.K. St. Louis, A.D. PatelAmerican Academy of Neurology

In partnership with

🔮 Wearables in Neurology: Advancements : Challenges : Future Potential🔮 

Neurology's Next Frontier: The Rise of Wearable Tech meaning!!!

Introduction:

  • Consumer-grade wearable technology is becoming integral to patient care, offering new opportunities and challenges.

  • The medical fraternity stands to benefit from the integration of wearables into clinical practice, especially in the areas of epilepsy, headache, cardiac (AFib/stroke prevention), and sleep disorders.

  • This report reviews clinical performance, risks, and emerging innovations of wearables in neurologic care.

Methods:

The report provides expert consensus on wearable technology, focusing on rapidly evolving devices.

  • The review is based on large-scale observational studies (e.g., Apple Heart Study), RCTs, and validation studies.

  • Key metrics include Positive Predictive Value (PPV), sensitivity, false alarm rates, and concordance with gold-standard diagnostics (e.g., Video-EEG, PSG, 12-lead ECG).

Key Findings:

1. Cardiac & AFib Screening:

  • Apple Heart Study: 419,000+ participants; 0.52% received irregular pulse notifications.

  • 34% of alerts confirmed AFib; anxiety reported in 20% of patients.

  • Limitations: PPG monitoring underperforms during high activity or tachycardia.

2. Epilepsy & Seizure Detection:

  • FDA-cleared smartwatches can detect tonic-clonic seizures via heart rate changes.

  • A ≥20% heart rate rise from baseline is a reliable seizure marker.

  • Machine learning models predicting seizure risk show promise but are not yet clinic-ready.

3. Headache & Migraine:

  • Biofeedback using wearables (HRV, EMG, temperature) shows strong evidence for migraine management at home.

  • Empatica E4 study showed decreased energy expenditure preictally in cluster headache patients.

  • Data attrition: Only 55.6% of participants provided complete datasets.

4. Sleep Architecture:

  • Wearables reliably track sleep-wake cycles and light/deep sleep stages in healthy adults.

  • However, they consistently underestimate Wake After Sleep Onset (WASO).

  • Proprietary algorithms often lack transparency, limiting clinical validation.

Results & Challenges:

  • Cardiac: 34% of alerts led to confirmed AFib in the Apple Heart Study, but PPG monitoring struggles with activity.

  • Epilepsy: Wearables detect seizures via heart rate changes but aren't fully ready for seizure prediction in clinical settings.

  • Headache: Biofeedback through wearables is effective for migraine management, but attrition rates limit clinical utility.

  • Sleep: Sleep-wake cycle tracking is reliable but underestimates WASO, raising concerns for clinical use in sleep disorders.

Impact:

  • Real-world utility: Wearables offer continuous, longitudinal monitoring, enabling patients to track health patterns outside the clinic.

  • Psychological impact: Anxiety is common due to false alerts (e.g., 15/16 adverse events in the Apple Heart Study).

  • Data privacy: Consumer devices are often not covered by HIPAA, raising concerns about data security.

  • False positives: Inaccurate alerts lead to unnecessary tests, costs, and patient distress, contributing to over-medicalization.

Conclusion: Wearables offer great potential for advancing neurologic care but pose risks and limitations that clinicians must navigate.

Recommendations:

  1. Screening vs. Diagnosis: Use wearables for screening only; confirm findings with medical-grade diagnostics.

  2. EHR Integration: Avoid data overload; integrate only actionable data into EHRs.

  3. Patient Adherence: Employ behavioral economics and digital navigators to improve patient engagement.

  4. Equity & Access: Address disparities in access, especially since insurance rarely reimburses for consumer devices.

  5. Ongoing Education: Stay updated on the evolving landscape of wearable technology.

Scale Your IRL Campaigns Like Digital Ads

Out Of Home advertising has long been effective but hard to scale—until now. AdQuick makes it simple to plan, deploy, and measure campaigns with the same efficiency and insight you expect from online marketing tools.

Marketers agree: OOH is powerful for brand growth, driving new customers, and reinforcing messaging. AdQuick makes it easy, intuitive, and data-driven—so you can treat real-world campaigns like any other digital channel.

Disclaimer: This newsletter contains opinions and speculations and is based solely on public information. It should not be considered medical, business, or investment advice. This newsletter's banner and other images are created for illustrative purposes only. All brand names, logos, and trademarks are the property of their respective owners. At the time of publication of this newsletter, the author has no business relationships, affiliations, or conflicts of interest with any of the companies mentioned except as noted. ** OPINIONS ARE PERSONAL AND NOT THOSE OF ANY AFFILIATED ORGANIZATIONS!

Reply

or to participate.